Top 10 Companies in the Global Glycan Biosynthesis Market (2026): Market Leaders Driving Innovation

MARKET INSIGHTS

Global glycan biosynthesis market was valued at USD 850 million in 2024, with projections indicating growth to USD 1.54 billion by 2032, at a compound annual growth rate (CAGR) of 8.3% during the forecast period. This expansion is driven by increasing applications in biologics development and rising demand for glycan-based therapeutics.

Glycan biosynthesis involves enzymatic processes that create complex carbohydrate structures essential for biological functions, including cell signaling, immune response modulation, and protein folding. Key glycan types include N-glycans (attached to asparagine residues) and O-glycans (linked to serine/threonine), which are critical in biopharmaceutical quality control and disease biomarker discovery.

Market growth is fueled by several factors: the expanding biopharmaceutical sector, increasing research into glycan-based vaccines (particularly for cancer immunotherapy), and technological advancements in glycan analysis tools. Notably, in Q1 2024, Creative Biolabs launched a novel high-throughput glycan synthesis platform, accelerating drug discovery timelines. However, challenges persist in standardization and scalability of glycan production methods. Leading players like Asparia Glycomics and Medicinal Chemistry Pharmaceuticals are investing heavily in enzymatic synthesis technologies to address these bottlenecks.

Global Glycan Biosynthesis Market – View in Detailed Research Report

---

Top 10 Companies in the Global Glycan Biosynthesis Market (2026)

1️⃣ 1. Medicinal Chemistry Pharmaceuticals

Headquarters: Madrid, Spain
Key Offering: Comprehensive glycobiology solutions, enzymatic synthesis, analytical platforms

Medicinal Chemistry Pharmaceuticals has established itself as a leader in glycobiology, offering a full suite of services from glycan synthesis to detailed structural analysis. Their proprietary enzymatic platform enables rapid production of N‑ and O‑glycans for biologic drug development, while their analytical tools provide high‑resolution profiling for quality control.

Sustainability & Growth Initiatives:

• Investment in green chemistry for glycan synthesis
• Strategic partnerships with leading biopharmaceutical firms
• Expansion of AI‑driven glycan analytics platform

2️⃣ 2. Asparia Glycomics

Headquarters: Barcelona, Spain
Key Offering: O‑glycan synthesis, glycan profiling services, vaccine development support

Asparia Glycomics specializes in O‑glycan engineering, providing customized synthesis and analytical services for therapeutic and vaccine applications. Their platform supports rapid scale‑up of complex glycans and offers detailed structural characterization to ensure product consistency.

Sustainability & Growth Initiatives:

• Development of scalable enzymatic processes
• Collaboration with academic institutions for glycan research
• Focus on low‑carbon manufacturing practices

3️⃣ 3. Creative Biolabs

Headquarters: San Diego, USA
Key Offering: High‑throughput glycan synthesis platform, analytical instrumentation, custom services

Creative Biolabs introduced a cutting‑edge high‑throughput glycan synthesis platform in Q1 2024, reducing production time and cost. Their integrated analytical suite, including mass spectrometry and chromatography, supports detailed glycan profiling for biologics and diagnostics.

Sustainability & Growth Initiatives:

• Automation of synthesis to lower energy consumption
• Partnerships with pharmaceutical companies to accelerate drug development
• Investment in AI‑powered data analysis tools

4️⃣ 4. Danaher Corporation (Beckman Coulter)

Headquarters: Waltham, USA
Key Offering: Glycan analysis instrumentation, workflow solutions, data management platforms

Danaher’s Beckman Coulter division brings robust instrumentation and software to the glycan market, enabling high‑throughput analysis and streamlined data integration for biopharmaceutical manufacturing.

Sustainability & Growth Initiatives:

• Expansion of glycan‑focused product lines
• Global distribution network to support emerging markets
• Commitment to sustainable lab practices

5️⃣ 5. Thermo Fisher Scientific

Headquarters: Waltham, USA
Key Offering: Mass spectrometry, chromatography, glycan analysis kits, software solutions

Thermo Fisher offers a comprehensive portfolio of analytical instruments and consumables for glycan profiling, supporting both research and industrial applications.

Sustainability & Growth Initiatives:

• Investment in next‑generation mass spectrometry
• Development of low‑volume, high‑accuracy assays
• Partnerships with biotech firms for platform integration

6️⃣ 6. Bio-Techne Corporation

Headquarters: Minneapolis, USA
Key Offering: Glycan reagents, kits, and antibodies for research and diagnostics

Bio-Techne provides a wide range of reagents and tools for glycan research, facilitating studies in cell signaling, immunology, and disease biomarkers.

Sustainability & Growth Initiatives:

• Development of sustainable reagent production
• Expansion of diagnostic assay portfolio
• Collaboration with academic labs for new applications

7️⃣ 7. Summit Therapeutics

Headquarters: London, UK
Key Offering: Glycan‑engineered biologics, vaccine adjuvants, diagnostic kits

Summit Therapeutics focuses on glycan‑engineered biologics for immunotherapy and vaccine enhancement, leveraging its expertise in glycan biology to improve efficacy and safety.

Sustainability & Growth Initiatives:

• Research into glycan‑based adjuvants for next‑generation vaccines
• Partnerships with global pharma for platform licensing
• Commitment to reducing environmental impact of production

8️⃣ 8. Lectenz Bio

Headquarters: San Diego, USA
Key Offering: Glycan synthesis enzymes, custom synthesis services, analytical support

Lectenz Bio specializes in enzyme engineering for glycan synthesis, providing tailored solutions for complex carbohydrate production in biopharmaceuticals.

Sustainability & Growth Initiatives:

• Engineering enzymes with higher catalytic efficiency
• Reducing waste through optimized reaction conditions
• Collaborations with academic centers for enzyme discovery

9️⃣ 9. Z Biotech, LLC

Headquarters: Boston, USA
Key Offering: Glycan analysis services, data interpretation, AI analytics

Z Biotech offers comprehensive glycan profiling services, integrating AI to accelerate data interpretation and support drug development pipelines.

Sustainability & Growth Initiatives:

• Implementation of AI for rapid data analysis
• Partnerships with pharma for scalable analytics
• Focus on data security and compliance

🔟 10. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Glycan synthesis kits, analytical platforms, biologic development services

Merck KGaA provides a range of glycan synthesis reagents and analytical tools, supporting the development of glyco‑engineered therapeutics and diagnostics.

Sustainability & Growth Initiatives:

• Investment in green chemistry for reagent production
• Expansion of biopharmaceutical service offerings
• Collaborations with global research institutions

---

Global Glycan Biosynthesis Market – View in Detailed Research Report

---

Global Glycan Biosynthesis Market – View in Detailed Research Report

---

Outlook: The Future of Glycan Biosynthesis Market

As the biopharmaceutical landscape evolves, glycan biosynthesis is poised to play a pivotal role in next‑generation therapeutics. Key drivers include the expansion of biologics, the rise of personalized medicine, and growing investment in glycan‑based diagnostics. The market is expected to grow at a robust CAGR, fueled by innovations in enzymatic synthesis, AI‑powered analytics, and scalable production technologies.

• Accelerated adoption of glycan‑engineered biologics in oncology and immunotherapy
• Expansion of glycan‑based diagnostic platforms for early disease detection
• Increased regulatory support for glycan characterization in drug approval
• Strategic partnerships between academia and industry to bridge technology gaps

---

Future Trends: Emerging Technologies and Market Expansion

Emerging trends in the glycan biosynthesis market are set to reshape the industry. From AI‑driven synthesis to next‑generation mass spectrometry, these innovations promise higher throughput, lower cost, and improved product quality.

• Artificial intelligence integration for predictive glycan design
• Automated high‑throughput synthesis platforms enabling rapid scale‑up
• Next‑generation mass spectrometry and chromatography for ultra‑high resolution profiling
• Expansion into cell and gene therapy applications, leveraging glyco‑engineering for improved delivery and efficacy
• Growth of glycan‑based liquid biopsy and point‑of‑care diagnostics across Asia‑Pacific markets